Resource Center
Resource Center
Until recently, many low- and middle-income countries were not able to provide HIV treatment to all patients due to the high cost of medication and treatment was reserved for only the sickest individuals. Decisions about whether or not to initiate patients on lifesaving antiretroviral therapy (ART) were often based on how far a patient’s disease...
Read moreCD4 cell count is an important diagnostic test to manage HIV-positive patients in low- and middle-income countries. CD4 testing is used to prioritize patients for treatment in settings where treatment is not accessible to all, monitor patients on treatment where viral load testing is not available, and monitor and manage patients with advanced HIV disease...
Read moreAddressing the gaps in HIV service delivery is critical to eliminating mother-to-child transmission of HIV. Even small gains in maternal retention on antiretroviral therapy (ART) can result in large gains in the number of children born HIV-free and significantly improves the health and survival of women and children. With timely identification of HIV status among...
Read moreArriving early in the morning to receive their HIV medications and beat the crowds, patients visiting resource-limited health facilities are often greeted by long lines. This was a problem experienced in some of the busiest health centers in Lusaka, Zambia, in 2014. While Zambia’s rate of HIV/AIDS prevalence is declining (12.9% in 2015 compared to...
Read moreIn urban areas, crowded HIV treatment facilities with long patient wait times can deter patients from attending their clinical appointments and picking up their medications, ultimately disrupting patient care and compromising patient retention and adherence. Since 2013, Zambia’s national antiretroviral treatment (ART) guidelines have recommended that stable patients be provided with prescriptions for up to...
Read moreThe Clinton Health Access Initiative, Inc. (CHAI) and the Ministry of Health of Zambia announce the release of new evidence regarding the integration of infant HIV testing with routine immunization services. Early testing of HIV-exposed infants and the initiation of antiretroviral therapy for HIV-positive infants is critical to improving infant survival. While Zambia has made...
Read moreDemand-Driven Evaluations for Decisions (3DE) is a pioneering approach to support ministries of health with evidence-based decision-making by using rigorous impact evaluations in a demand-driven, rapid, and efficient way. Learn more about the 3DE approach in this program overview.
Read moreCHAI’s Research and Development (R&D) Team works from a unique angle to support CHAI’s ambitions to improve patient outcomes in low- and middle-income countries. In particular, the team works to: 1. Identify, develop, validate, and transfer for manufacture and distribution better and less expensive drug formulations of existing HIV/AIDS, tuberculosis (TB), and malaria medicines; 2....
Read moreCHAI's Demand-Driven Evaluations for Decisions (3DE) program is a pioneering approach to support ministries in the health sector with evidence-based decision-making by using rigorous impact evaluations in a demand-driven, rapid, and efficient way.
Read moreIn late July Vancouver hosted the 8th annual International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment & Prevention. Over 20 CHAI staff members from around the world presented a wide variety of work at the meeting. The conference was characterized by a few themes, among them a continued commitment to the ambitious “90-90-90” target:...
Read more